AUM
$789M
Estimated Dry Powder
$16.7M
Fund Size (Latest)
Perseus-Soros Biopharmaceutical Fund
$448.8M
Estimated Cheque Size
$4.5M-$44.9M
Stages
- Seed
- Series A
- Series B
Fund Details
Year Established
2000
HQ
489 5th Avenue,10th Floor, New York, NY, 10017, US, North America
HQ Phone
+1 212 651 6380
About
Aisling Capital is a US-based private equity firm specializing in products, technologies, and global businesses that advance health. The firm primarily focuses on life science companies developing biopharmaceutical products and advanced life science technologies across US. Aisling Capital invests in both public and private companies, often serving as the lead or co-lead investor in most of its investments.
HQ Map
No mappable locations available.
Locations
Tel: +1 212 651 6380View map